Dr. Ajay Sharma

Dr. Ajay Sharma is the Senior Director and Unit Head of Medical Oncology at BLK-Max Super Speciality Hospital in New Delhi, bringing over 18 years of dedicated expertise in comprehensive cancer care. He is a Fellow of the European Society for Medical Oncology (ESMO) and holds the prestigious European Certification in Medical Oncology (ECMO) from Amsterdam, alongside his MD from Sher-i-Kashmir Institute of Medical Sciences and DNB in Medical Oncology from Rajiv Gandhi Cancer Institute. His clinical foundation is exceptionally strong, built on rigorous training and progressive leadership roles across India's premier oncology centres.

Dr. Sharma's clinical practice spans the full spectrum of solid tumour management, with particular mastery in breast cancer, head and neck cancers, and advanced malignancies. He specialises in multimodal treatment strategies including adjuvant and neoadjuvant chemotherapy, immunotherapy for advanced cancers, immune checkpoint inhibitor therapy, and precision molecular-targeted therapies guided by biomarker analysis. His evidence-based approach to hormone therapy in breast cancer and targeted treatment of solid tumours has made him a trusted clinician within India's oncology community. As Unit Head at BLK-Max, he oversees comprehensive cancer programmes and leads multidisciplinary teams to manage complex cases.

Dr. Sharma regularly treats international patients from the Gulf region, East Africa, and Central Asian countries who seek his expertise for second opinions and definitive cancer treatment. His fluency in English and Hindi, combined with his international training credentials and membership in both ASCO (American Society of Clinical Oncology) and ESMO, ensures seamless communication and globally-aligned care standards. He understands the unique needs of patients travelling for treatment, from initial consultation through follow-up management.

BLK-Max Super Speciality Hospital, where Dr. Sharma practises, is one of New Delhi's most advanced oncology destinations, equipped with state-of-the-art chemotherapy suites, molecular diagnostics laboratories, and dedicated palliative care units. The hospital maintains NABH accreditation and offers robust international patient support, including visa assistance and accommodation coordination. For patients seeking medical oncology care in India, Dr. Sharma's combination of international certification, institutional leadership, and proven outcomes makes BLK-Max an excellent choice for comprehensive, evidence-based cancer treatment tailored to each patient's unique tumour biology and clinical stage.